封面
市場調查報告書
商品編碼
1622498

皮膚助推劑市場規模、佔有率、成長分析、按類型、性別、最終用途、按地區 - 行業預測,2025-2032 年

Skin Boosters Market Size, Share, Growth Analysis, By Type (Mesotherapy, Micro-Needle), By Gender (Female, Male), By End-Use, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023年Skin Booster的市場規模為10,748.2億美元,將從2024年的11,726.3億美元成長到2032年的23,537.5億美元,在預測期內(2025-2032年)預計複合年成長率為9.1%。 。

由於消費者對護膚和美容的興趣日益濃厚,全球皮膚促進劑市場正處於強勁成長軌道。這些基於透明質酸的微創美容填充劑可滿足非手術程序的需求,以最短的停機時間提供自然的效果。隨著皮膚病發病率的上升,老齡化人口的迅速增加,尋求預防與老齡化相關的衰退正在推動巨大的市場興趣。技術的進步導致了創新配方和更好的給藥方法的開發,提高了治療的功效和安全性。北美目前在高消費支出和強大的醫療基礎設施的支持下主導市場,但由於可支配收入的增加和美容標準的變化,亞太地區正在迅速崛起。儘管面臨監管審查和成本障礙等挑戰,但在持續的技術創新和不斷擴大的客戶群的支持下,皮膚促進劑市場預計將繼續成長。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 監管環境
  • Start-Ups分析
  • 專利分析
  • 貿易分析

皮膚促進劑市場規模:按類型和複合年成長率(2025-2032)

  • 市場概況
  • 美塑療法
    • 玻尿酸
    • 維他命
    • 礦物
  • 微型針
    • 皮膚填充劑
    • 富血小板血漿 (PRP)

皮膚促進劑市場規模:性別與複合年成長率(2025-2032)

  • 市場概況
  • 女士
  • 男性

皮膚促進劑市場規模:依最終用途和複合年成長率(2025-2032)

  • 市場概況
  • 皮膚科診所
  • 梅迪斯帕

皮膚促進劑市場規模:按地區和複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較(2022-2024)

主要企業簡介

  • Galderma SA(Switzerland)
  • Merz Aesthetics(Germany)
  • Bloomage Biotechnology Corporation Limited(China)
  • Teoxane Laboratories(Switzerland)
  • Filorga(France)
  • Professional Derma SA(Switzerland)
  • IBSA-Institute Biochemical SA(Switzerland)
  • Revance Therapeutics, Inc.(USA)
  • Suneva Medical, Inc.(USA)
  • Anika Therapeutics, Inc.(USA)
  • Prollenium Medical Technologies Inc.(Canada)
  • Revitrane(South Korea)
  • Caregen Co., Ltd.(South Korea)
  • Hugel, Inc.(South Korea)
  • Daewoong Pharmaceutical Co., Ltd.(South Korea)
  • LG Chem Ltd.(South Korea)
  • Hyundai Bioscience Co., Ltd.(South Korea)
  • Medytox Inc.(South Korea)
  • Croma-Pharma GmbH(Austria)

結論和建議

簡介目錄
Product Code: SQMIG35D2259

Skin Boosters Market size was valued at USD 1074.82 Billion in 2023 and is poised to grow from USD 1172.63 Billion in 2024 to USD 2353.75 Billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global skin booster market is on a robust growth trajectory, propelled by heightened consumer interest in skincare and aesthetic enhancements. These minimally invasive cosmetic injectables, primarily composed of hyaluronic acid, cater to the demand for non-surgical procedures that deliver natural results with minimal downtime. The surge in the aging population seeking to combat signs of aging, alongside a rising prevalence of skin conditions, is significantly driving market interest. Technological advancements have led to innovative formulations and superior delivery methods, enhancing treatment efficacy and safety. North America currently dominates the market, fueled by high consumer spending and a strong healthcare infrastructure, while the Asia-Pacific region is rapidly emerging due to increasing disposable income and changing beauty norms. Despite challenges like regulatory scrutiny and cost barriers, the skin booster market is expected to flourish, underpinned by ongoing innovation and an expanding client base.

Top-down and bottom-up approaches were used to estimate and validate the size of the Skin Boosters market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Skin Boosters Market Segmental Analysis

Global Skin Boosters Market is segmented by type, gender, end-use and region. Based on type, the market is segmented into mesotherapy and micro-needle. Based on gender, the market is segmented into female and male. Based on end-use, the market is segmented into dermatology clinics and medspa. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Skin Boosters Market

The Skin Boosters market is being driven by a growing desire among individuals to maintain a youthful and photogenic appearance. The COVID-19 pandemic and the rise of remote work have significantly increased the demand for wrinkle treatments as more people participate in virtual meetings and interviews, where a polished look is essential. Social media platforms, particularly Instagram and Facebook, amplify this trend, pushing individuals to enhance their skincare for better online representation. Additionally, the influence of online personalities who share lifestyle and beauty tips has further fueled this enthusiasm. Industry leaders are tapping into this phenomenon by collaborating with popular influencers to effectively market their skincare solutions.

Restraints in the Skin Boosters Market

The Skin Boosters market is hindered by several restraints, primarily revolving around high product costs and limited penetration among consumers. The expense associated with these treatments is a major challenge, as prices are shaped by the practitioner's expertise, the techniques used, and the overall complexity of the procedure. Additionally, since skin boosters offer temporary results, clients may find themselves needing further treatments down the line, adding to their financial commitment. This potential for ongoing costs can discourage many individuals from pursuing these options, leading them to prefer more affordable skincare alternatives that do not involve injections or invasive procedures.

Market Trends of the Skin Boosters Market

The Skin Boosters market is witnessing a significant trend driven by an increasing emphasis on preventive skincare among consumers. As individuals become more health-conscious and seek to maintain youthful, radiant skin, there's a growing adoption of skin boosters known for their ability to enhance hydration, improve elasticity, and combat early signs of aging. This proactive approach signifies a shift in consumer behavior, favoring treatments that not only address existing skin concerns but also serve as a long-term investment in skin health. As a result, the demand for innovative and effective skin booster products is rapidly expanding, shaping the future of skincare.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Startup Analysis
  • Patent Analysis
  • Trade Analysis

Global Skin Boosters Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Mesotherapy
    • Hyaluronic Acid
    • Vitamins
    • Minerals
  • Micro-Needle
    • Dermal Fillers
    • Platelet-Rich Plasma (PRP)

Global Skin Boosters Market Size by Gender & CAGR (2025-2032)

  • Market Overview
  • Female
  • Male

Global Skin Boosters Market Size by End-Use & CAGR (2025-2032)

  • Market Overview
  • Dermatology Clinics
  • MedSpa

Global Skin Boosters Market Size & CAGR (2025-2032)

  • North America (Type, Gender, End-Use)
    • US
    • Canada
  • Europe (Type, Gender, End-Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Gender, End-Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Gender, End-Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Gender, End-Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Galderma S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Aesthetics (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloomage Biotechnology Corporation Limited (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teoxane Laboratories (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Filorga (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Professional Derma SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBSA - Institute Biochemical SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revance Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suneva Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prollenium Medical Technologies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revitrane (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Caregen Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hugel, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Daewoong Pharmaceutical Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LG Chem Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hyundai Bioscience Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medytox Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croma-Pharma GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations